Article

Black, Asian Lupus Patients Referred to Specialists Less Often

Author(s):

In a study announced at the 2016 American College of Rheumatology Annual Meeting in Washington, DC, lupus patients with less education were also likely to wait longer for referral to a specialist.

A complex disease with varied manifestations, lupus typically requires specialized, individualized treatment. A study announced at the 2016 American College of Rheumatology Annual Meeting in Washington, DC, however, found that such specialized care is not distributed equally to all lupus patients.

Researchers from the California Pacific Medical Center and from the University of California San Francisco reached this conclusion after an examination of data from the California Lupus Epidemiology Study (CLUES). In a selection of just under 200 patients, they explored race, education, and socioeconomic status in diagnosis and care of the disease.

The group was mixed: 33% Asian, 30% Caucasian, 22% Hispanic, and 14% African-American. In terms of education, 13% had high school or less, and 34% were determined to have “limited health literacy.”

Among this set, about a third of patients went a year between onset of symptoms and actual lupus diagnosis, which was consistent across the demographic groups. What was inconsistent, however, was what came after diagnosis.

While 92% of white patients and 85% of Hispanic patients were referred to a specialist within three months of diagnosis, only 66% of Asians and 64% black patients did. Additionally, only 45% of those with a high school education or less were referred in that time.

It is important to note that the study’s 196 patients are split into demographic groups, creating increasingly smaller samples. Still, Lisa Gaynon, MD, of the California Pacific Medical Center, believes this work is important in an effort to “identify populations who are at a significant disadvantage when it comes to accessing specialist care for their lupus,” citing the need to go further in determining what factors, like the geographic distribution of rheumatology specialists or the insurance status of patients, may play a role.

Related Coverage:

“A Joint Operation”: Rheumatologists, Orthopedists Collaborate to Improve Patient Outcomes

Study Bolsters Link Between Psoriatic Arthritis and Fibromyalgia

ACR Proposes Recommendations for Glucocorticoid-Induced Osteoporosis

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.